LOCUS       ABV13292.1               760 aa    PRT              BCT 31-JAN-2014
DEFINITION  Citrobacter koseri ATCC BAA-895 hypothetical protein protein.
ACCESSION   CP000822-2113
PROTEIN_ID  ABV13292.1
SOURCE      Citrobacter koseri ATCC BAA-895
  ORGANISM  Citrobacter koseri ATCC BAA-895
            Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
            Enterobacteriaceae; Citrobacter.
REFERENCE   1  (bases 1 to 4720462)
  AUTHORS   McClelland,M., Sanderson,E.K., Porwollik,S., Spieth,J.,
            Clifton,W.S., Latreille,P., Courtney,L., Wang,C., Pepin,K.,
            Bhonagiri,V., Nash,W., Johnson,M., Thiruvilangam,P. and Wilson,R.
  CONSRTM   The Citrobacter koseri Genome Sequencing Project
  TITLE     Direct Submission
  JOURNAL   Submitted (29-AUG-2007) Genetics, Genome Sequencing Center, 4444
            Forest Park Parkway, St. Louis, MO 63108, USA
COMMENT     Citrobacter (diversus) koseri--Citrobacter cells are isolated from
            water, sewage, soils, and food, as well as from the feces of man
            and other animals, where they may be normal inhabitants. They can
            be found in urine, sputum, and other clinical specimens. They can
            sometimes be opportunistic pathogens particularly in
            immunocompromised patients in hospitals or in infants (Pepperell et
            al., Antimicrob Agents Chemother. 2002 Nov;46(11):3555-60. and
            references therein).
            
            The strain of Citrobacter koseri being sequenced, strain CDC
            4225-83, was isolated in 1983 in Maryland, where it caused neonatal
            meningitis. It was provided by Caroline Mohr and Melissa Campbell
            of CDC. The strain is available from the American Type Culture
            Collection as ATCC BAA-895 or from the Salmonella Genetic Stock
            Centre as SGSC4696. The genome was sequenced to 8X coverage, using
            plasmid and fosmid libraries and was finished to an error rate of
            less than 1 per 10,000 bases. Automated annotation was performed
            and manual annotation will continue in the labs of Michael
            McClelland and Kenneth Sanderson. The National Institute of Allergy
            and Infectious Diseases (NIAID), National Institutes of Health
            (NIH) has funded this project.
            
            Coding sequences below are predicted using GeneMark v3.3 and
            Glimmer2 v2.13.Intergenic regions not spanned by GeneMark and
            Glimmer2 were blasted against NCBI's non-redundant (NR) database
            and predictions generated based on protein alignments. RNA genes
            were determined usingtRNAscan-SE 1.23 or Rfam v8.0. This sequence
            was finished as follows unless otherwise noted: all regions were
            double stranded, sequenced with an alternate chemistries or covered
            by high quality data (i.e., phred quality >=30); an attempt was
            made to resolve all sequencing problems, such as compressions and
            repeats; all regions were covered by sequence from more than one
            m13 subclone.
FEATURES             Qualifiers
     source          /organism="Citrobacter koseri ATCC BAA-895"
                     /mol_type="genomic DNA"
                     /strain="ATCC BAA-895"
                     /db_xref="ATCC:BAA-895"
                     /db_xref="taxon:290338"
     protein         /locus_tag="CKO_02168"
                     /inference="protein motif:HMMPfam:IPR001150"
                     /inference="protein motif:HMMPfam:IPR004184"
                     /inference="protein motif:HMMTigr:IPR005949"
                     /inference="protein motif:ScanRegExp:IPR001150"
                     /note="KEGG: stm:STM0973 0. pflB; pyruvate formate lyase I
                     K00656; COG: COG1882 Pyruvate-formate lyase; Psort
                     location: Cytoplasmic, score:9.97"
                     /transl_table=11
                     /db_xref="InterPro:IPR001150"
                     /db_xref="InterPro:IPR004184"
                     /db_xref="InterPro:IPR005949"
BEGIN
        1 MSELNEKLAT AWEGFTKGDW QNEVNVRDFI QKNYTPYEGD ESFLAGATNA TTALWDSVME
       61 GVKQENRTHA PVDFDTSVAS TITSHDAGYI NKALEKIVGL QTEAPLKRAI IPFGGIKMVE
      121 GSCKAYNREL DPMLKKIFTE YRKTHNQGVF DVYTKDILNC RKSGVLTGLP DAYGRGRIIG
      181 DYRRVALYGI DFLMKDKYAQ FVSLQSDLEN GVNLEATIRL REEIAEQHRA LGQIKEMAAK
      241 YGCDISGPAT NAQEAIQWTY FGYLAAVKSQ NGAAMSFGRV STFLDAYIER DIKAGKITEQ
      301 DAQEMIDHLV MKLRMVRFLR TPEYDELFSG DPIWATESIG GMGVDGRTLV TKNSFRFLNT
      361 LYTMGPSPEP NITVLWSEKL PLNFKKFAAK VSIDTSSLQY ENDDLMRPDF NNDDYAIACC
      421 VSPMVVGKQM QFFGARANLA KTMLYAINGG VDEKLKMQVG PKSEPIKGDV LNFDEVMDRM
      481 DHFMDWLAKQ YVTALNVIHY MHDKYSYEAS LMALHDRDVI RTMACGIAGL SVAADSLSAI
      541 KYAKVKPIRD EDGLAVDFEI EGEYPQFGNN DSRVDDMAVD LVERFMKKIQ KLTTYRGAIP
      601 TQSVLTITSN VVYGKKTGNT PDGRRAGAPF GPGANPMHGR DQKGAVASLT SVAKLPFAYA
      661 KDGISYTFSI VPNALGKDDE VRKTNLAGLM DGYFHHEASI EGGQHLNVNV MNREMLLDAM
      721 EHPEKYPQLT IRVSGYAVRF NSLTKEQQQD VITRTFTQTM
//